Also, the aldosterone receptor antagonists can alleviate myocardial fibrosis, inhibit the excessive secretion of aldosterone, and reduce the phenomenon of “aldosterone escape” [6–8]. Here, NR3C2 is linked to Myocardial fibrosis.